Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The week's dominant story is earnings. UnitedHealth Group and Johnson & Johnson both report Q3 results this morning. J&J carries a $630bn market cap, making it the largest print of the week. Bank of America follows tomorrow before the open. Charles Schwab, BNY Mellon, and Nordic lender Nordea Bank report Thursday. The week closes with and on Friday. Investors are focused on net interest income and loan demand across the financials.
Options flow is turning bearish on semiconductors. NVDA, AMD, and MU led negative put flow over the past seven days. The AI-linked rally has stalled again. Defensive names are absorbing the rotation. ADP, Equinix, and CSX all registered 100% positive options flow over the same window.
Short interest in Chewy jumped nearly 20 percentage points in a week to 87.3% of free float. Medtronic saw a sharp 8.5-point rise to 10.1%. Heavy-industry analyst targets also moved lower across PACCAR, Caterpillar, and Cummins, signalling cooling confidence in the industrial cycle.
The MSCI November rebalance is six days from its 19 October cut-off. Moderna sits 90% likely to be added to MSCI World, with $4.8bn of forced buying expected. On the deletion side, Flutter Entertainment jumped to 86% probability of removal overnight, with $589M of forced selling at stake. Mid-America Apartment Communities also moved sharply to 84%, with $761M on the line.
The Copart tender for ACV Auctions carries 93% completion probability and could be effective as early as 19 October. Italian pharma name Recordati faces potential FTSE MIB deletion if CVC Capital Partners' agreed offer closes by mid-November. Austrian new-car registrations rose 13% year on year in September 2026, a bright spot against a subdued European auto backdrop.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
